問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
高嘉宏
下載
2022-09-01 - 2026-08-31
Condition/Disease
Test Drug
Participate Sites2Sites
Recruiting2Sites
2020-01-01 - 2025-12-31
Participate Sites3Sites
Recruiting1Sites
Terminated2Sites
2023-02-15 - 2025-06-30
Participate Sites11Sites
Recruiting10Sites
Terminated1Sites
2024-10-15 - 2029-10-31
Recruiting3Sites
2023-06-01 - 2026-12-31
Participate Sites7Sites
Recruiting7Sites
2023-11-09 - 2032-11-22
2026-01-01 - 2033-02-28
Participate Sites6Sites
Recruiting6Sites
2025-01-01 - 2032-12-31
Participate Sites12Sites
Recruiting12Sites
2022-09-01 - 2025-03-07
Participate Sites4Sites
Recruiting4Sites
2024-01-12 - 2026-09-11
Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Efruxifermin
Not yet recruiting4Sites
Study ended1Sites
全部
